Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice
- 31 January 2008
- journal article
- Published by Elsevier BV in Biologicals
- Vol. 36 (1), 41-47
- https://doi.org/10.1016/j.biologicals.2007.05.003
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Glycosylation of Recombinant Antibody TherapeuticsBiotechnology Progress, 2008
- Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regionsMolecular Immunology, 2000
- Antigen Binding of an Ovomucoid-specific Antibody is Affected by a Carbohydrate Chain Located on the Light Chain Variable RegionBioscience, Biotechnology, and Biochemistry, 2000
- The structure and evolution of FcRnResearch in Immunology, 1996
- Biological and physicochemical characterization of recombinant human erythropoietins fractionated by Mono Q column chromatography and their modification with sialytransferaseGlycoconjugate Journal, 1996
- Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.The Journal of Experimental Medicine, 1994
- Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibodyMolecular Immunology, 1993
- Asymmetrically glycosylated IgG isolated from non-immune human seraBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- Possible role for peptide-oligosaccharide interactions in differential oligosaccharide processing at asparagine-107 of the light chain and asparagine-297 of the heavy chain in a monoclonal IgG1.kappa.Biochemistry, 1984
- A monoclonal immunoglobulin G1 in which some molecules possess glycosylated light chains—I. Site of glycosylationMolecular Immunology, 1981